Diabetes, hyperglycaemia, and acute ischaemic stroke (Q37984922)

26 August 2017

Diabetes, hyperglycaemia, and acute ischaemic stroke (English)

1 reference

26 August 2017

1 reference

Merel J A Luitse

1

1 reference

26 August 2017

Geert Jan Biessels

series ordinal

2

1 reference

26 August 2017

Guy E H M Rutten

series ordinal

3

1 reference

26 August 2017

L Jaap Kappelle

series ordinal

4

1 reference

26 August 2017

language of work or name

1 reference

1 March 2012

1 reference

26 August 2017

1 reference

26 August 2017

11

1 reference

26 August 2017

3

1 reference

26 August 2017

261-271

1 reference

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

26 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Update in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

1 reference

7 January 2021

Gender differences and temporal variation in the incidence of type 1 diabetes: results of 8012 cases in the nationwide Diabetes Incidence Study in Sweden 1983-2002.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Type 2 diabetes: principles of pathogenesis and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

The changing world demography of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

1 reference

7 January 2021

Impact of the population at risk of diabetes on projections of diabetes burden in the United States: an epidemic on the way.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Risk factors for diabetes mellitus by age and sex: results of the National Population Health Survey

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

1 reference

7 January 2021

Long-term effect of diabetes and its treatment on cognitive function.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Cardiovascular disease in insulin dependent diabetes mellitus: similar rates but different risk factors in the US compared with Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

ABC of arterial and venous disease: vascular complications of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Preventing stroke: saving lives around the world.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Cognition and diabetes: a lifespan perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Hyperglycemia in aneurysmal subarachnoid hemorrhage: a potentially modifiable risk factor for poor outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Risk factors for cardiovascular mortality and morbidity: the WHO Mutinational Study of Vascular Disease in Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Prospective Study of Type 1 and Type 2 Diabetes and Risk of Stroke Subtypes: The Nurses' Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/Northern Kentucky Stroke Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Are lacunar strokes really different? A systematic review of differences in risk factor profiles between lacunar and nonlacunar infarcts

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Diabetes mellitus and risk of stroke and its subtypes among Japanese: the Japan public health center study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Risk factors for ischemic stroke subtypes: the Atherosclerosis Risk in Communities study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the northern Manhattan study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Fasting and post-glucose load measures of insulin resistance and risk of ischemic stroke in older adults

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Long term postischemic stroke mortality in diabetes: a veteran cohort analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Diabetes mellitus and ischemic stroke in the young: clinical features and long-term prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Cause of Stroke Recurrence Is Multifactorial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Long-term lifestyle intervention lowers the incidence of stroke in Japanese patients with type 2 diabetes: a nationwide multicentre randomised controlled trial (the Japan Diabetes Complications Study).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Carotid endarterectomy for symptomatic carotid stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Glucose control and vascular complications in veterans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Effects of intensive glucose lowering in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Long-term effects of intensive glucose lowering on cardiovascular outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Effects of intensive blood-pressure control in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Effects of combination lipid therapy in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Effect of a multifactorial intervention on mortality in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Long-term follow-up after tight control of blood pressure in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Meta-analysis of randomized educational and behavioral interventions in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Long-term durability of carotid endarterectomy for symptomatic stenosis and risk factors for late postoperative stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Diabetes mellitus is a predictor for early adverse outcome after carotid endarterectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Moderate hyperglycaemia is associated with favourable outcome in acute lacunar stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Stress hyperglycaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Persistent hyperglycemia at 24-48 h in acute hyperglycemic stroke patients is not associated with a worse functional outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Hyperglycemia and cognitive outcome after ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Hyperglycaemia and infarct size in animal models of middle cerebral artery occlusion: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Factor VIIa and tissue factor procoagulant activity in diabetes mellitus after acute ischemic stroke: impact of hyperglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Hyperglycemia: a prothrombotic factor?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Perfusion deficit parallels exacerbation of cerebral ischemia/reperfusion injury in hyperglycemic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Neuronal nitric oxide synthase and human vascular regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood-brain barrier dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Increased oxidative stress during hyperglycemic cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Association of admission blood glucose and outcome in patients treated with intravenous thrombolysis: results from the Safe Implementation of Treatments in Stroke International Stroke Thrombolysis Register (SITS-ISTR).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Post-thrombolytic hyperglycemia and 3-month outcome in acute ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Hyperglycemia in patients with focal cerebral ischemia after intravenous thrombolysis: influence on clinical outcome and infarct size

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Thrombolysis outcomes in acute ischemic stroke patients with prior stroke and diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Hyperglycaemic crises and lactic acidosis in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Hyperglycemic hemianopia: a reversible complication of non-ketotic hyperglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Intensive insulin therapy in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Intensive Insulin Therapy in Mixed Medical/Surgical Intensive Care Units: Benefit Versus Harm

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Intensive insulin therapy in hospitalized patients: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Glucose Regulation in Acute Stroke Patients (GRASP) trial: a randomized pilot trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Pragmatic management of hyperglycaemia in acute ischaemic stroke: safety and feasibility of intensive intravenous insulin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Subjecting acute ischemic stroke patients to continuous tube feeding and an intensive computerized protocol establishes tight glycemic control.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Intravenous insulin therapy in the maintenance of strict glycemic control in nondiabetic acute stroke patients with mild hyperglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Efficacy and safety of two 5 day insulin dosing regimens to achieve strict glycaemic control in patients with acute ischaemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

A randomised, controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycaemic acute ischaemic stroke patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Computer-assisted glucose control in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Insulin for glycaemic control in acute ischaemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the A

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970005-4

7 January 2021

10.1016/S1474-4422(12)70005-4

Identifiers

DOI

1 reference

26 August 2017

1 reference